Related Experiment Video
Updated: Jun 5, 2026
04:30
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Animal models of restenosis
1Cardiovascular Diseases Research, DuPont Merck Pharmaceutical Company Experimental Station E400/3251, Wilmington, DE 19880-0400, USA.
Trends in Cardiovascular Medicine
|January 20, 2011
Summary
Developing better animal models for restenosis is crucial for creating new therapies. Improving anatomical and pathophysiological resemblance to humans enhances drug efficacy prediction for coronary artery disease treatments.
Area of Science:
- Cardiovascular Research
- Translational Medicine
- Animal Models
Background:
- Percutaneous transluminal coronary angioplasty (PTCA) is a common procedure to open blocked arteries.
- Restenosis, the re-narrowing of arteries after PTCA, significantly limits treatment effectiveness.
- Predictive animal models are needed to develop novel therapies for restenosis.
Purpose of the Study:
- To explore strategies for enhancing the predictivity of animal models for human restenosis.
- To identify key areas for improvement in current restenosis research models.
Main Methods:
- Reviewing two primary approaches to improve animal model predictivity: anatomical/procedural and pathophysiological/molecular resemblance.
- Analyzing the progress and challenges associated with each approach.
Main Results:
- Advancements are being made in creating animal models that mimic human anatomy and PTCA procedures.
- Progress in developing models with high pathophysiological and molecular similarity is hindered by incomplete understanding of human restenosis biology.
Conclusions:
- Improving anatomical and procedural similarity in animal models is achievable and progressing.
- Further research into the fundamental biology of human restenosis is essential for developing more predictive models and effective therapies.
